All of them can make you feel breathless. Doctors use stages to describe how severe your COPD is. This system is called the GOLD staging or grading system. Your grade will affect what treatment you ...
The experimental therapy tozorakimab from AstraZeneca was superior to a placebo at reducing the rate of moderate to severe exacerbations, or sudden episodes of symptom worsening, in adults with ...
Regeneron Pharmaceuticals, Inc. REGN and partner Sanofi SNY announced mixed results from two late-stage studies, AERIFY-1 and AERIFY-2, on itepekimab for the treatment of chronic obstructive pulmonary ...
Shares of AstraZeneca rose on Friday after the drugmaker reported positive results from late-stage clinical trials of its ...
Phase 2 trial launched for verekitug in COPD, expanding treatment indications for severe respiratory conditions. Top data expected in 2026. Upstream Bio, Inc. has initiated a global Phase 2 clinical ...
Add Yahoo as a preferred source to see more of our stories on Google. Finding out that you or a loved one has chronic obstructive pulmonary disease (COPD) can feel overwhelming. But the good news is ...
Investor's Business Daily on MSN
AstraZeneca zips higher on its double win in COPD treatment
AstraZeneca stock jumped Friday after the U.K.-based drugmaker said its COPD drug succeeded in two final-phase studies.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results